Hepatitis B vaccines
J Pattyn, G Hendrickx, A Vorsters… - The Journal of …, 2021 - academic.oup.com
Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to
chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a …
chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a …
Hepatitis B vaccines
SY Andy, RC Cheung, EB Keeffe - Infectious Disease Clinics, 2006 - id.theclinics.com
More than 350 million people worldwide are infected with the hepatitis B virus (HBV), and
more than 1 million of them die each year of liver failure or hepatocellular carcinoma …
more than 1 million of them die each year of liver failure or hepatocellular carcinoma …
Hepatitis B vaccines: protective efficacy and therapeutic potential
ML Michel, P Tiollais - Pathologie Biologie, 2010 - Elsevier
Worldwide, two billion people have at some time been infected by hepatitis B virus, 370
millions suffer from chronic infection and around one million die each year from HBV-related …
millions suffer from chronic infection and around one million die each year from HBV-related …
Prevention of hepatitis B
MH Chang, DS Chen - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
Hepatitis B virus (HBV) causes life-threatening liver disease. It is transmitted through a
horizontal route or a mother-to-infant route, and the latter is the major route in endemic …
horizontal route or a mother-to-infant route, and the latter is the major route in endemic …
The global impact of vaccination against hepatitis B: a historical overview
AR Zanetti, P Van Damme, D Shouval - Vaccine, 2008 - Elsevier
Hepatitis B virus (HBV) infection is a world wide public health problem of major concern.
HBV infection may lead to chronic liver disease, including cirrhosis and hepatocellular …
HBV infection may lead to chronic liver disease, including cirrhosis and hepatocellular …
[HTML][HTML] Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B
DS Chen - Journal of hepatology, 2009 - Elsevier
Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people
are chronically infected with the virus. They continue to spread the virus to others and are …
are chronically infected with the virus. They continue to spread the virus to others and are …
[HTML][HTML] Hepatitis B virus: where do we stand and what is the next step for eradication?
H Komatsu - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Abstract Hepatitis B (HB) virus (HBV) infection, which causes liver cirrhosis and
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …
[HTML][HTML] Hepatitis B vaccine and immunoglobulin: key concepts
S Das, K Ramakrishnan, SK Behera… - Journal of clinical and …, 2019 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine
practice. The target of such vaccination is to induce the immune response in the host …
practice. The target of such vaccination is to induce the immune response in the host …
[HTML][HTML] The global impact of hepatitis B vaccination on hepatocellular carcinoma
JE Flores, AJ Thompson, M Ryan, J Howell - Vaccines, 2022 - mdpi.com
Over 1.5 million preventable new hepatitis B infections continue to occur each year and
there are an estimated 296 million people living with chronic hepatitis B infection worldwide …
there are an estimated 296 million people living with chronic hepatitis B infection worldwide …
[HTML][HTML] Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine
Hepatitis B virus (HBV) infection is a global health problem. It is estimated there are more
than 2 billion individuals exposed to the virus and 250 million are chronically infected …
than 2 billion individuals exposed to the virus and 250 million are chronically infected …